BIOADAPTIVES, INC. Quarterly Interest Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Bioadaptives, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2018 to Q3 2024.
  • Bioadaptives, Inc. Interest Expense for the quarter ending September 30, 2024 was $9.7K, a 53% decline year-over-year.
  • Bioadaptives, Inc. Interest Expense for the twelve months ending September 30, 2024 was $121K, a 43.2% decline year-over-year.
  • Bioadaptives, Inc. annual Interest Expense for 2023 was $163K, a 43.7% decline from 2022.
  • Bioadaptives, Inc. annual Interest Expense for 2022 was $289K, a 6.14% increase from 2021.
  • Bioadaptives, Inc. annual Interest Expense for 2021 was $272K, a 18.3% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $121K $9.7K -$10.9K -53% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $132K $18K -$34.3K -65.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $166K $54.6K +$3.55K +6.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $163K $39K -$50.6K -56.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-10
Q3 2023 $213K $20.6K -$73.5K -78.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 $287K $52.3K -$23.1K -30.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $310K $51.1K +$21K +69.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 $289K $89.5K -$41.1K -31.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-10
Q3 2022 $330K $94.1K +$29.6K +45.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $301K $75.4K +$59.5K +376% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $241K $30.1K -$31.3K -51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $272K $131K -$28.2K -17.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $301K $64.5K -$1.67K -2.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $302K $15.8K -$43.1K -73.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $345K $61.4K +$115K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $230K $159K +$105K +196% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $125K $66.2K +$18K +37.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $107K $58.9K +$10.3K +21.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $96.8K -$53.6K -$103K -209% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $199K $53.6K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $48.2K +$208K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $48.6K +$25.5K +111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $49K Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-06-11
Q3 2018 -$159K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $23.1K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.